Daniel Gesua Sive Salvadori - 27 Feb 2026 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Reporting relationship: EVP AND GROUP PRESIDENT
Issuer ticker: ABT
Reported as of: 27 Feb 2026
Net transaction value: -$871,348
SEC form: 4
Accepted by SEC: 03 Mar 2026, 20:10:48 UTC
Prior SEC filing: 26 Feb 2026
Source filing: View source filing
Reporting owner signature: /s/ Daniel Gesua Sive Salvadori by Jessica H. Paik, Attorney-in-Fact

Key filing fact

Daniel Gesua Sive Salvadori filed Form 4 for ABBOTT LABORATORIES (ABT) on 03 Mar 2026.

Key facts

This page summarizes Daniel Gesua Sive Salvadori's Form 4 filing for ABBOTT LABORATORIES (ABT).
2 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 03 Mar 2026, 20:10.

Change

Previous filing in this sequence was filed on 26 Feb 2026.
Current net transaction value: -$871,348.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001620564 Primary reporting owner

Salvadori Daniel Gesua Sive

Relationship: EVP AND GROUP PRESIDENT
Address: 100 ABBOTT PARK ROAD, ABBOTT PARK
Signature: /s/ Daniel Gesua Sive Salvadori by Jessica H. Paik, Attorney-in-Fact
Signature date: 03 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

ABT transaction

Common shares without par value

Tax liability

Transaction value: $769,060
Shares: -6,615
Change %: -4.3%
Price: $116.26
Shares after: 147,262
Date: 27 Feb 2026
Ownership: Direct

ABT transaction

Common shares without par value

Sale

Transaction value: $102,288
Shares: -885
Change %: -0.6%
Price: $115.58
Shares after: 146,377
Date: 02 Mar 2026
Ownership: Direct

^* marks a reported price that did not pass the local price check.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .